North
America
VRE (E. faecium) 66.9%
MRSA 53.2%
ESBL-K. pneumoniae 9.8%
A.
baumannii
(IMP-R) 13.5%
P.
aeruginosa
(IMP-R) 15.0%
Enterobacter spp. (Caz-R) 35.7%
Latin
America
VRE (E. faecium) 49.6%
MRSA
46.2%
ESBL-K. pneumoniae 38.6%
A. baumannii (IMP-R) 37.5%
P. aeruginosa (IMP-R) 33.2%
Enterobacter spp. (Caz-R) 33.3%
Asia
Pacific
VRE (E. faecium) 23.6%
MRSA 41.2%
ESBL-K. pneumoniae 20.9%
A. baumannii (IMP-R) 35.5%
P.
aeruginosa
(IMP-R) 18.1%
Enterobacter spp. (Caz-R) 60.0%
Europe
VRE (E. faecium) 15.1%
MRSA 25.4%
ESBL-K. pneumoniae 16.4%
A.
baumannii
(IMP-R) 15.0%
P.
aeruginosa
(IMP-R) 17.4%
Enterobacter spp. (Caz-R) 42.8%
Available at www.testsurveillance.com. accessed
June 11, 2010
多重抗藥性細菌因地區略有不同
